S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
OTCMKTS:ZRSEF

DocMorris (ZRSEF) Stock Price, News & Analysis

$88.60
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$88.60
$88.60
50-Day Range
$75.80
$99.49
52-Week Range
$33.00
$99.49
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ZRSEF stock logo

About DocMorris Stock (OTCMKTS:ZRSEF)

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

ZRSEF Stock Price History

ZRSEF Stock News Headlines

The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
Leafly Holdings Inc LFLY
DocMorris AG ZRE
DocMorris AG DOCM
DocMorris N.V.
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
DocMorris AG ZRSEF
Pineapple Inc PNPL
Clicks Group Ltd ADR CLCGY
Zur Rose delays profitability break-even to 2024
Zur Rose Group: Ist das der Beginn einer Trendwende?
Citi Upgrades Zur Rose Group AG to Neutral
ROSEG.S - | Stock Price & Latest News | Reuters
See More Headlines
Receive ZRSEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocMorris and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Retailers
Sub-Industry
N/A
Current Symbol
OTCMKTS:ZRSEF
CIK
N/A
Fax
N/A
Employees
2,283
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Walter Oberhansli (Age 66)
    Founder & Chairman
    Comp: $320k
  • Mr. Walter Hess (Age 59)
    CEO & Member of Executive Board
    Comp: $1.22M
  • Mr. Marcel Ziwica (Age 49)
    CFO & Member of Executive Board
  • Mr. David Maso (Age 53)
    Head of Europe & Member of Executive Board
  • Mr. Madhu Nutakki (Age 53)
    CTO & Member of Executive Board
  • Mr. Kaspar Niklaus (Age 56)
    COO & Member of Executive Board
  • Dr. Daniel Grigat
    Group Head of Investor Relations & Sustainability
  • Lisa Luthi
    Head of Corporate Communications

ZRSEF Stock Analysis - Frequently Asked Questions

Should I buy or sell DocMorris stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DocMorris in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZRSEF shares.
View ZRSEF analyst ratings
or view top-rated stocks.

How have ZRSEF shares performed in 2024?

DocMorris' stock was trading at $75.80 at the beginning of 2024. Since then, ZRSEF stock has increased by 16.9% and is now trading at $88.60.
View the best growth stocks for 2024 here
.

Are investors shorting DocMorris?

DocMorris saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 209,900 shares, an increase of 23.6% from the February 29th total of 169,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,099.0 days.
View DocMorris' Short Interest
.

How do I buy shares of DocMorris?

Shares of ZRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ZRSEF) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners